
Hangzhou Gaoguang Pharmaceutical
Small molecule drugs for treatment of autoimmune diseases and cancer.
Date | Investors | Amount | Round |
---|---|---|---|
* | CNY150m | Late VC | |
Total Funding | 000k |
Related Content
Highlightll Pharmaceutical USA LLC is dedicated to discovering breakthrough medicines with significant impacts on healthcare. The company operates globally, not confined to a single region or therapeutic area, and combines worldwide resources and expertise with its unique perspectives to address challenging medical problems. Highlightll differentiates itself by seeking competitive advantages in all its projects. Its lead program features the world's first highly potent and selective dual TYK2 JAK1 inhibitor, showcasing its commitment to high-impact solutions. The business primarily serves the healthcare sector, focusing on developing advanced pharmaceutical solutions. Revenue is generated through the development and commercialization of these innovative medicines.
Keywords: pharmaceuticals, healthcare, global, breakthrough, medicines, TYK2, JAK1, inhibitor, expertise, competitive